000 03781nam a22003615i 4500
001 279539
003 MX-SnUAN
005 20160429153949.0
007 cr nn 008mamaa
008 150903s2009 xxu| o |||| 0|eng d
020 _a9780387786087
_99780387786087
024 7 _a10.1007/9780387786087
_2doi
035 _avtls000332940
039 9 _a201509030759
_bVLOAD
_c201404122314
_dVLOAD
_c201404092049
_dVLOAD
_y201402041058
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
100 1 _aWebster, Thomas J.
_eeditor.
_9303930
245 1 0 _aSafety of Nanoparticles :
_bFrom Manufacturing to Medical Applications /
_cedited by Thomas J. Webster.
264 1 _aNew York, NY :
_bSpringer New York,
_c2009.
300 _axii, 239 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aNanostructure Science and Technology,
_x1571-5744
500 _aSpringer eBooks
505 0 _aDeveloping Practices for Safe Handling of Nanoparticles and Nanomaterials in a Development-Stage Enterprise: A Practical Guide for Research and Development Organizations -- Cytotoxicity of Photoactive Nanoparticles -- Breeching Epithelial Barriers – Physiochemical Factors Impacting Nanomaterial Translocation and Toxicity -- Safety and Efficacy of Nano/Micro Materials -- Biomedical Applications of Nanoparticles -- Unexpected Reactions by In Vivo Applications of PEGylated Liposomes -- Hydrogel Nanocomposites: Biomedical Applications, Biocompatibility, and Toxicity Analysis -- Cytotoxicity and Genotoxicity of Carbon Nanomaterials -- Calcium Phosphate Nanoparticles: Toxicology and Lymph Node Targeting for Cancer Metastasis Prevention -- Nanoparticles for Cancer Diagnosis and Therapy.
520 _a"Environmental safety and health has become an existential issue for the nanotechnology movement, and the international community is responding to this challenge with major multi-disciplinary research efforts. This compilation covers both the toxicology and biomedical applications of nanomaterials in a form that will be a useful reference and starting point for people working in or entering this rapidly growing field." --Dr. Robert Hurt, Director, The Institute for Molecular and Nanoscale Innovation (IMaNI) at Brown University, Professor, Brown University, Providence, RI 02917 USA In spite of the potential use of nanomaterials as tissue engineering devices, implants, biosensors, drug delivery devices, etc., there has yet to be a compilation of the risks associated with the in vivo use of nanomaterials. There are numerous and well-known risks because of the size of nanoparticles. For example, nanoparticles can cross cell membranes and enter the cytoplasm undetected. The aim of this book is to provide one of the first detailed overviews of how cells and tissues in the body deal with nanoparticles. This is important not only for implantable devices, but also for the manufacturing of nanophase materials when particles can be inhaled or enter the body through the skin. Only by compiling research at the intersection of nanoparticles and biological processes can we determine if nanophase materials are safe to be manufactured, handled, and/or implanted for various medical applications.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9780387786070
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-78608-7
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c279539
_d279539